Applied Therapeutics faces challenges after FDA rejection, but future opportunities exist. Learn why APLT stock could recover ...

Dev4All, 4P-Pharma's cutting-edge R&D booster, announces a strategic collaboration with Pharmaseed, an established Contract ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

The Madras High Court has held that magic mushroom per se does not satisfy the requirement of a narcotic drug or a ...

People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themsel ...

Apple's new holiday commercial highlights the AirPods Pro 2's new hearing aid features. Here's how you can use the device for people hard of hearing.

Alumis is advancing ESK-001 for plaque psoriasis with phase 3 data expected in 2026. Read why ALMS stock is compelling yet ...

In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control ...

Through this acquisition, the German CDMO expands its global network and adds aseptic fill/finish and lyophilization expertise to its sterile manufacturing capabilities.

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...

FTR’s Shippers Conditions Index improved in September to 4.6 from the 2.9 reading in August due to lower fuel costs, looser ...